RXILIENT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RXILIENT Trademark

Serial Number: 79390919

RXILIENT is a trademark filed by Rxilient Health Pte. Ltd. on December 1, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Rxilient Health Pte. Ltd. (3 trademarks)

1 COLEMAN STREET,

Entity Type: 24

Trademark Details

Filing Date

December 1, 2023

Registration Date

Not Registered

Goods & Services

Apparatus for administering pharmaceuticals; applicators for pharmaceutical preparations; devices for use in the administration of pharmaceuticals; injection device for pharmaceuticals; medical apparatus for introducing pharmaceutical preparations into the human body; analytical apparatus for medical purposes; apparatus for medical diagnostic purposes; apparatus for medical testing; apparatus for use in medical analysis; detecting apparatus for medical use; electronic medical apparatus; electronic medical instruments; electronic monitoring apparatus for medical use; medical apparatus and instruments; dermabraders for treating skin disorders; dermabrasion apparatus for medical and therapeutic purposes; microdermabrasion apparatus for medical or therapeutic purposes; laser light treatment instruments for medical use; medical lasers for cosmetic treatment purposes; medical lasers for beauty therapy; therapeutic cosmetic treatment apparatus; ophthalmic cameras for medical purposes; optical apparatus for medical diagnostic use; optical apparatus for medical purposes; diagnostic instruments for ophthalmology

Consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development services; pharmaceutical research consultancy; pharmaceutical testing; conducting early evaluations in the field of new pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; providing information about the results of clinic trials for pharmaceuticals; research and development for the pharmaceutical industry; services for assessing the efficiency of pharmaceuticals; technical research in the field of pharmaceutical studies; biomedical research services; medical research services; clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes; advisory services relating to biochemistry; advisory services relating to pharmacology software; design and development of new products for others; design and development of medical technology; development of pharmaceuticals; dna sequencing for medical research purposes; product quality evaluation; research and development services for the pharmaceutical industry; scientific research services; scientific testing services in the field of medical equipment

Dermatological services for treating skin conditions; providing medical advice in the field of dermatology; providing medical information in the field of dermatology; advisory services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to pharmaceutical products; dispensing of pharmaceuticals; providing pharmaceutical advice; pharmaceutical consultancy services; provision of pharmaceutical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; ophthalmology services; advisory services relating to medicines; beauty care consultancy; beauty treatment services; consultancy relating to skin care; health care consultancy; laboratory analysis services relating to the treatment of persons; medical analysis services relating to the treatment of persons; providing information relating to medicine

Advertising services relating to pharmaceutical products and in-vivo imaging products; advertising services relating to pharmaceutical products; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for medical apparatus; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services in relation to medical apparatus; administrative services in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting services in the field of medical product approval for commercial purposes; business administration services; business consultancy and advisory services; business management; business strategic planning; compilation of statistics for business or commercial purposes; conducting business feasibility studies; data processing for the collection of data for business purposes; advertising, namely promotion of business; advertising, marketing and promotion services; development of marketing strategies and concepts

Cosmetics; non-medicated skin care preparations; non-medicated cleaning preparations for the skin; non-medicated cleansing preparations for the skin; anti-ageing creams; anti-freckle creams; anti-wrinkle creams; cosmetic creams for firming skin around eyes; cosmetic creams for firming the skin; cosmetic creams for the skin; cosmetic preparations for the care of the skin; cosmetic preparations for cleansing the skin; cosmetic preparations for protecting the skin from the sun's rays; cosmetic preparations for use on the skin; cosmetic skin care lotions; cosmetic skin cleansers; cosmetic skin lotions; cosmetics for the treatment of dry skin; non-medicated clarifying facial toners; cold creams; cream for skin whitening; non-medicated essences for skin care; non­medicated exfoliants for the care of the skin; non-medicated skin toners; non­medicated creams for protection of the skin; non-medical preparations for the care of the skin; non-medicated skin care beauty preparations; oils for the skin in the nature of skin and body topical oils for cosmetic use; non­medicated revitalizing skin creams; air-fragrancing preparations; aromatics being essential oils; oils for cosmetic purposes; serums for cosmetic purposes

Medical training and teaching; publication of the results of clinical trials for pharmaceutical preparations; arranging and conducting business conferences; organisation of conferences and symposia in the field of medical science; arranging and conducting of educational events; arranging and conducting of seminars; arranging and conducting of workshops and seminars; publication of electronic publications; publication of printed matter; training for handling scientific instruments and apparatus for research in laboratories; training in the field of data processing; training in the field of medicine.

Filing History

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 9, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 9, 2025 PARI
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 6, 2025 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 11, 2025 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2025 TROA
ASSIGNED TO EXAMINER
Sep 29, 2024 DOCK
REFUSAL PROCESSED BY IB
Aug 11, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 1, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 30, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2024 REPR